-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains In-Line on Hims & Hers Health, Raises Price Target to $27

Benzinga·11/10/2026 14:03:14
Diffusion vocale
Evercore ISI Group analyst Mark Mahaney maintains Hims & Hers Health (NYSE:HIMS) with a In-Line and raises the price target from $24 to $27.